Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.
2.

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.

de Castria TB, da Silva EM, Gois AF, Riera R.

Cochrane Database Syst Rev. 2013 Aug 16;(8):CD009256. doi: 10.1002/14651858.CD009256.pub2. Review.

PMID:
23949842
3.

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):327-39. Review.

PMID:
11441939
4.

Chemotherapy for advanced non-small cell lung cancer in the elderly population.

Santos FN, de Castria TB, Cruz MR, Riera R.

Cochrane Database Syst Rev. 2015 Oct 20;(10):CD010463. doi: 10.1002/14651858.CD010463.pub2. Review.

PMID:
26482542
5.

Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.

Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL.

Cochrane Database Syst Rev. 2014 Nov 17;(11):CD009948. doi: 10.1002/14651858.CD009948.pub2. Review.

PMID:
25400254
6.

Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.

Mannion E, Gilmartin JJ, Donnellan P, Keane M, Waldron D.

Support Care Cancer. 2014 May;22(5):1417-28. doi: 10.1007/s00520-014-2148-9. Epub 2014 Feb 22. Review.

PMID:
24563068
7.

A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.

Tanvetyanon T, Soares HP, Djulbegovic B, Jacobsen PB, Bepler G.

J Thorac Oncol. 2007 Dec;2(12):1091-7. Review.

8.
9.

Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?

Numico G, Russi E, Merlano M.

Lung Cancer. 2001 Jun;32(3):213-26. Review.

PMID:
11390003
10.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
11.

Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.

Curran MP, Plosker GL.

Drugs Aging. 2002;19(9):695-721. Review.

PMID:
12381238
12.
13.

Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer.

Plosker GL, Hurst M.

Pharmacoeconomics. 2001;19(11):1111-34. Review.

PMID:
11735678
14.

Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.

Chu Q, Vincent M, Logan D, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care..

Lung Cancer. 2005 Dec;50(3):355-74. Epub 2005 Aug 31. Review.

PMID:
16139391
15.

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R.

Health Technol Assess. 2013 Jul;17(31):1-278. doi: 10.3310/hta17310. Review. Erratum in: Health Technol Assess. 2015 May;17(31):281-2.

16.

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.

Rossi A, Chiodini P, Sun JM, O'Brien ME, von Plessen C, Barata F, Park K, Popat S, Bergman B, Parente B, Gallo C, Gridelli C, Perrone F, Di Maio M.

Lancet Oncol. 2014 Oct;15(11):1254-62. doi: 10.1016/S1470-2045(14)70402-4. Epub 2014 Sep 14. Review.

PMID:
25232001
17.

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.

Greenhalgh J, Dwan K, Boland A, Bates V, Vecchio F, Dundar Y, Jain P, Green JA.

Cochrane Database Syst Rev. 2016 May 25;(5):CD010383. doi: 10.1002/14651858.CD010383.pub2. Review.

PMID:
27223332
18.

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.

Vilmar A, Sørensen JB.

Lung Cancer. 2009 May;64(2):131-9. doi: 10.1016/j.lungcan.2008.08.006. Epub 2008 Sep 19. Review.

PMID:
18804893
20.

Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.

Harper P.

Semin Oncol. 2003 Aug;30(4 Suppl 10):2-12. Review.

PMID:
12917815

Supplemental Content

Support Center